| Literature DB >> 31205027 |
Andras Iring1, Young-June Jin1, Julián Albarrán-Juárez1, Mauro Siragusa2,3, ShengPeng Wang1,4, Péter T Dancs5, Akiko Nakayama1, Sarah Tonack1, Min Chen6, Carsten Künne7, Anna M Sokol8, Stefan Günther7, Alfredo Martínez9, Ingrid Fleming2,3, Nina Wettschureck1,3,10, Johannes Graumann3,8, Lee S Weinstein6, Stefan Offermanns1,3,10.
Abstract
Hypertension is a primary risk factor for cardiovascular diseases including myocardial infarction and stroke. Major determinants of blood pressure are vasodilatory factors such as nitric oxide (NO) released from the endothelium under the influence of fluid shear stress exerted by the flowing blood. Several endothelial signaling processes mediating fluid shear stress-induced formation and release of vasodilatory factors have been described. It is, however, still poorly understood how fluid shear stress induces these endothelial responses. Here we show that the endothelial mechanosensitive cation channel PIEZO1 mediated fluid shear stress-induced release of adrenomedullin, which in turn activated its Gs-coupled receptor. The subsequent increase in cAMP levels promoted the phosphorylation of endothelial NO synthase (eNOS) at serine 633 through protein kinase A (PKA), leading to the activation of the enzyme. This Gs/PKA-mediated pathway synergized with the AKT-mediated pathways leading to eNOS phosphorylation at serine 1177. Mice with endothelium-specific deficiency of adrenomedullin, the adrenomedullin receptor, or Gαs showed reduced flow-induced eNOS activation and vasodilation and developed hypertension. Our data identify fluid shear stress-induced PIEZO1 activation as a central regulator of endothelial adrenomedullin release and establish the adrenomedullin receptor and subsequent Gs-mediated formation of cAMP as a critical endothelial mechanosignaling pathway regulating basal endothelial NO formation, vascular tone, and blood pressure.Entities:
Keywords: G-protein coupled receptors; Hypertension; Vascular Biology; endothelial cells
Year: 2019 PMID: 31205027 PMCID: PMC6597232 DOI: 10.1172/JCI123825
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808